AGREEMENTAgreement • February 14th, 2014 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Halozyme Therapeutics, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them.
